Summit Therapeutics plc Gains 38.65%

Tue, Dec 13, 2022 at 07:09 PM
Summit Therapeutics plc Gains 38.65%

Summit Therapeutics plc (SMMT:NASDAQ) rocketted at $3.91, representing a gain of 38.7%. On Tue, Dec 13, 2022, SMMT:NASDAQ touched a New 2-Week Intraday High of $4.15. The stock got featured on our News Catalysts scanner on Fri, Dec 09, 2022 at 10:05 AM in the 'INSIDER' category. From Tue, Nov 29, 2022, the stock recorded 60.00% Up Days and 63.64% Green Days

The stock spiked on Thu, Dec 08, 2022 at $4.5 with a volume of 89M+.

About Summit Therapeutics plc (SMMT:NASDAQ)

Summit Therapeutics PLC is a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines for indications for which there are no existing or only inadequate therapies.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.